West Chester, PA, United States of America

Maria Maccecchini

This inventor holds 12 USPTO granted patents and 12 published patent applications and 2 EPO patents, primarily in Neurological Treatments. Top assignees: Annovis Bio, Inc., Qr Pharma, Inc., Synthes USA, LLC. Active years: 2011-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Maria Maccecchini. Retrieved from https://idiyas.com/inventor/maria-maccecchini

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 12 (Patent Applications = 12)

% Patents Active = 100.0

EPO Patents = 2 (Patent Applications = 4)

Average Co-Inventor Count = 1.1

ph-index = 1

Forward Citations = 4(Granted Patents)

Company Filing History:

Years Active: 2011-2026

Loading Chart...

Areas of Expertise:

Posiphen

Neurodegeneration

Neurological Injuries

Butanetap

Metal Dis-homeostasis

Acute Brain Injuries

Treatment Methods

Solid Forms

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12780831 - Solid forms of posiphen D-tartrate (2026-11-03),

2. 12582632 - Inhibition of neurological injuries due to infections via administration of Butanetap and analogs thereof (2026-03-24),

3. 12390448 - Prevention or of disease states due to metal dis-homeostasis via administration of posiphen to healthy or sick humans (2025-08-19),

4. 12144798 - (3aR)-1,3a,8-trimethyl-1,2,3,3a,8,8ahexahydropyrrolo[2,3-b]indol-5-yl phenylcarbamate and methods of treating or preventing neurodegeneration (2024-11-19),

5. 12042482 - Methods of treatment or prevention of acute brain or nerve injuries (2024-07-23),

6. 11596621 - Prevention or treatment of disease states due to metal dis-homeostasis via administration of Posiphen to healthy or sick humans (2023-03-07),

7. 11400075 - (3aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-5-yl phenylcarbamate and methods of treating or preventing neurodegeneration (2022-08-02),

8. 11382893 - (3aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-5-yl phenylcarbamate and methods of treating or preventing neurodegeneration (2022-07-12),

9. 11376238 - (3aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-5-yl phenylcarbamate and methods of treating or preventing neurodegeneration (2022-07-05),

10. 11096926 - (3AR)-1,3A,8-trimethyl-1,2,3,3A,8,8A-hexahydropyrrolo[2,3-b]indol-5-yl phenylcarbamate and methods of treating or preventing neurodegeneration (2021-08-24),

11. 10383851 - (3aR)-1,3a,8-Trimethyl-1 ,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-5-yl phenylcarbamate and methods of treating or preventing neurodegeneration (2019-08-20),

12. 7914810 - Methods for the in situ treatment of bone cancer (2011-03-29),

Title: Innovations and Contributions of Maria Maccecchini

Introduction

Maria Maccecchini is a prominent inventor based in West Chester, Pennsylvania. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment and prevention of neurodegenerative diseases. With a total of 10 patents to her name, her work has the potential to impact the health and well-being of many individuals.

Latest Patents

One of her latest patents focuses on the prevention of disease states due to metal dis-homeostasis through the administration of Posiphen. This invention outlines a method for maintaining heavy metal homeostasis in healthy individuals by administering a pharmaceutical composition containing Posiphen or its pharmaceutically acceptable salts. The treatment is designed to be administered once daily and aims to prevent potential disease states such as neurodegenerative diseases, cardiovascular issues, and cancer.

Another significant patent involves the compound (3aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-5-yl phenylcarbamate. This invention provides a method for treating or preventing neurodegeneration and neurotoxicity in subjects in need of such treatment.

Career Highlights

Maria has worked with notable companies in the pharmaceutical industry, including Annovis Bio, Inc. and Synthes USA, LLC. Her experience in these organizations has contributed to her expertise and innovative approach to addressing complex health issues.

Collaborations

[This section has been skipped due to space constraints.]

Conclusion

Maria Maccecchini's work exemplifies the impact of innovation in the pharmaceutical field. Her patents and contributions are paving the way for advancements in the treatment of serious health conditions.

Profile summary based on public USPTO records.